The weekly visit itself is quick, and you can generally continue with your daily activities immediately afterward
While specific renal dose adjustments are not routinely required for GLP-1 receptor agonists or tirzepatide, patients should be monitored for dehydration and potential kidney injury, particularly when starting treatment
The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION)
This distinction is important because while the two share a pathway, their purpose, strength, and outcomes arent the same
States that do cover GLP-1 medications for weight loss often impose additional barriers such as prior authorization requirements, step therapy (requiring patients to fail cheaper medications first), or BMI thresholds above 35 kg/m
[PubMed Citation] Pregnant animal studies Reproductive and developmental toxicity studies performed in rats at oral doses up to 6.7 times the recommended human intravenous dose and in rabbits at doses up to 3.3 times the recommended human intravenous dose revealed no evidence of impaired fertility or embryofetal toxicity
